Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma

被引:16
作者
Palmsten, Kristin [1 ]
Hulugalle, Avanthi [1 ,2 ]
Bandoli, Gretchen [1 ]
Kuo, Grace M. [3 ,4 ]
Ansari, Shayda [1 ]
Xu, Ronghui [4 ,5 ]
Chambers, Christina D. [1 ,4 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
[2] NYU, Coll Global Publ Hlth, New York, NY USA
[3] Univ Calif San Diego, Div Clin Pharm, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[5] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
asthma; medication; pharmacoepidemiology; pregnancy; rheumatoid arthritis; WOMEN; DELIVERY; COHORT; RISK;
D O I
10.1111/ppe.12415
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThere are limited data regarding the comparability of medication exposure information during pregnancy from maternal report and medical records, including for rheumatoid arthritis and asthma-related medications. MethodsThis study included pregnant women with rheumatoid arthritis (n = 216) and asthma (n = 172) enrolled in the MothertoBaby Pregnancy Studies (2009-2014). Women reported types and dates of medications used through semi-structured telephone interviews up to three times during pregnancy and once after delivery, and medical records were obtained. We calculated Cohen's kappa coefficients and 95% confidence intervals (CIs) and per cent agreement for agreement between report and records. ResultsFor rheumatoid arthritis, prednisone was reported most frequently (53%). During pregnancy, kappa coefficients for rheumatoid arthritis medications ranged from 0.32 (95% CI 0.15, 0.50) for ibuprofen, with 84.3% agreement, to 0.90 (95% CI 0.84, 0.96) for etanercept with 95.4% agreement, and was 0.44 (95% CI 0.33, 0.55) for prednisone, with 71.3% agreement. For asthma, albuterol was reported most frequently (77.9%). During pregnancy, kappa coefficients for asthma medications ranged from 0.21 (95% CI 0.08, 0.35), with 64.5% agreement for albuterol to 0.84 (95% CI 0.71, 0.96) for budesonide/formoterol, with 96.5% agreement. Where kappas for any use during pregnancy were less than excellent (i.e. 0.80), medication use was more frequently captured by report than record. ConclusionsAgreement was higher for medications typically used continuously than sporadically. Information on medication use from medical records alone may not be adequate when studying the impact of intermittently used medications during pregnancy on perinatal outcomes.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 29 条
[1]   Prescription drug use in pregnancy [J].
Andrade, Susan E. ;
Gurwitz, Jerry H. ;
Davis, Robert L. ;
Chan, K. Arnold ;
Finkelstein, Jonathan A. ;
Fortman, Kris ;
McPhillips, Heather ;
Raebel, Marsha A. ;
Roblin, Douglas ;
Smith, David H. ;
Yood, Marianne Ulcickas ;
Morse, Abraham N. ;
Platt, Richard .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (02) :398-407
[2]   Disease Severity and Pregnancy Outcomes in Women with Rheumatoid Arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project [J].
Bharti, Balambal ;
Lee, Susan J. ;
Lindsay, Suzanne P. ;
Wingard, Deborah L. ;
Jones, Kenneth L. ;
Lemus, Hector ;
Chambers, Christina D. .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) :1376-1382
[3]   Maternal treatment with opioid analgesics and risk for birth defects [J].
Broussard, Cheryl S. ;
Rasmussen, Sonja A. ;
Reefhuis, Jennita ;
Friedman, Jan M. ;
Jann, Michael W. ;
Riehle-Colarusso, Tiffany ;
Honein, Margaret A. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (04) :314.e1-314.e11
[4]   The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications [J].
Bonnie Bruce ;
James F Fries .
Health and Quality of Life Outcomes, 1 (1)
[5]   Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy [J].
Chambers, Christina D. ;
Johnson, Diana L. ;
Robinson, Luther K. ;
Braddock, Stephen R. ;
Xu, Ronghui ;
Lopez-Jimenez, Janina ;
Mirrasoul, Nicole ;
Salas, Elizabeth ;
Luo, Yunjun J. ;
Jin, Shelia ;
Jones, Kenneth Lyons .
ARTHRITIS AND RHEUMATISM, 2010, 62 (05) :1494-1503
[6]   DRUG-USE IN PREGNANCY - A COMPARATIVE APPRAISAL OF DATA COLLECTING METHODS [J].
DEJONGVANDENBERG, LTW ;
WAARDENBURG, CM ;
HAAIJER-RUSKAMP, FM ;
DUKES, MNG ;
WESSELING, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (01) :9-14
[7]   Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database [J].
Espnes, Marte Gravseth ;
Bjorge, Tone ;
Engeland, Anders .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (03) :243-248
[8]   A method to automate probabilistic sensitivity analyses of misclassified binary variables [J].
Fox, MP ;
Lash, TL ;
Greenland, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (06) :1370-1376
[9]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145
[10]  
Hollingshead AB, 1975, 4 FACTOR INDE UNPUB